Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
11776
PUT
Liberty Latin America Class A
LILA
$1.76B
| $52.7K | ﹤0.01% |
8,096
+6,477
| +400% | +$42.4K |
2022 Q4
7 quarters
|
|
11777
Better Online Solutions
BOSC
$32.6M
| $52.7K | ﹤0.01% |
17,856
+1,323
| +8% | +$3.82K |
2024 Q1
2 quarters
|
|
|
ARC
11778
DELISTED
ARC Document Solutions, Inc.
ARC
| $52.6K | ﹤0.01% |
15,563
-34,315
| -69% | -$107K |
2022 Q2
9 quarters
|
|
11779
PUT
Direxion Daily Transportation Bull 3X ETF
TPOR
$15.4M
| $52.6K | ﹤0.01% |
+1,600
| New | +$47.1K |
2024 Q3
0 quarters
|
|
|
TURN
11780
DELISTED
180 Degree Capital
TURN
| $52.6K | ﹤0.01% |
15,606
+11,800
| +310% | +$40.7K |
2022 Q4
7 quarters
|
|
11781
CALL
Standard BioTools
LAB
$282M
| $52.5K | ﹤0.01% |
27,200
+14,400
| +113% | +$28.2K |
2020 Q2
17 quarters
|
|
11782
CALL
Blue Owl Capital
OBDC
$4.87B
| $52.5K | ﹤0.01% |
3,600
+100
| +3% | +$1.5K |
2021 Q4
11 quarters
|
|
11783
PUT
Scilex Holding
SCLX
$26.5M
| $52.3K | ﹤0.01% |
1,617
+1,343
| +490% | +$64.3K |
2023 Q2
5 quarters
|
|
11784
5E Advanced Materials
FEAM
$161M
| $52.2K | ﹤0.01% |
4,205
+2,325
| +124% | +$44K |
2024 Q2
1 quarter
|
|
11785
Oramed Pharmaceuticals
ORMP
$184M
| $52.2K | ﹤0.01% |
+21,402
| New | +$52.2K |
2024 Q3
0 quarters
|
|
11786
Freightos
CRGO
$45.8M
| $52.2K | ﹤0.01% |
+36,239
| New | +$61K |
2024 Q3
0 quarters
|
|
11787
PUT
Savara
SVRA
$1.03B
| $52.2K | ﹤0.01% |
12,300
-79,500
| -87% | -$351K |
2024 Q1
2 quarters
|
|
11788
PUT
Health Catalyst
HCAT
$133M
| $52.1K | ﹤0.01% |
6,400
+4,600
| +256% | +$33.2K |
2022 Q3
8 quarters
|
|
|
SHCO
11789
CALL
DELISTED
Soho House & Co
SHCO
| $52K | ﹤0.01% |
10,200
+7,100
| +229% | +$38.9K |
2022 Q4
7 quarters
|
|
|
MGIC
11790
CALL
DELISTED
Magic Software Enterprises
MGIC
| $52K | ﹤0.01% |
4,400
+600
| +16% | +$6.52K |
2022 Q4
7 quarters
|
|
11791
PUT
CEL-SCI Corp
CVM
$36.9M
| $51.9K | ﹤0.01% |
1,633
+216
| +15% | +$7.61K |
2019 Q2
21 quarters
|
|
|
CMRX
11792
PUT
DELISTED
Chimerix, Inc.
CMRX
| $51.9K | ﹤0.01% |
55,800
+4,700
| +9% | +$4.19K |
2022 Q4
7 quarters
|
|
11793
PUT
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.4B
| $51.9K | ﹤0.01% |
1,200
-2,400
| -67% | -$94.6K |
2022 Q4
7 quarters
|
|
|
NIXX
11794
Nixxy Inc
NIXX
$8.71M
| $51.8K | ﹤0.01% |
+18,912
| New | +$40.3K |
2024 Q3
0 quarters
|
|
11795
CALL
ASE Group
ASX
$119B
| $51.7K | ﹤0.01% |
5,300
+1,300
| +33% | +$13.2K |
2022 Q1
10 quarters
|
|
11796
PUT
Global X Blockchain ETF
BKCH
$278M
| $51.7K | ﹤0.01% |
1,100
-400
| -27% | -$19.1K |
2023 Q4
3 quarters
|
|
11797
PUT
ProKidney
PROK
$332M
| $51.6K | ﹤0.01% |
26,900
+9,300
| +53% | +$21.1K |
2023 Q4
3 quarters
|
|
11798
PUT
Gossamer Bio
GOSS
$64.3M
| $51.6K | ﹤0.01% |
654
-74
| -10% | -$5.7K |
2022 Q3
8 quarters
|
|
11799
CALL
Neumora Therapeutics
NMRA
$85.2M
| $51.5K | ﹤0.01% |
3,900
+800
| +26% | +$9.33K |
2023 Q4
3 quarters
|
|
11800
PUT
Kimbell Royalty Partners
KRP
$1.5B
| $51.5K | ﹤0.01% |
3,200
-16,900
| -84% | -$272K |
2021 Q1
14 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.